Uniklinikum Salzburg

The department leverages advanced neuroimaging to enhance diagnosis and guide treatment of brain and spinal disorders.

• Acute ischemic stroke with incomplete reperfusion
• Primary generalized tonic‑clonic seizures
• Early Parkinson’s disease
• Primary progressive multiple sclerosis
• Pediatric brain tumors such as medulloblastoma

Ongoing trials aim to evaluate novel therapeutic agents and device‑based interventions, seeking to improve functional recovery and long‑term neurological outcomes.

Cutting‑edge imaging supports the assessment of solid and hematologic cancers across all stages.

• Advanced breast cancer (ER+/HER2‑)
• Non‑small cell lung cancer with molecular alterations
• Melanoma, including high‑risk resected disease
• Prostate cancer, localized and metastatic
• Pediatric sarcomas such as Ewing sarcoma
• Acute myeloid leukemia and related myelodysplastic syndromes

Studies focus on targeted therapies, immunotherapies, and combination regimens to increase survival and reduce disease recurrence.

Research integrates vascular imaging with clinical evaluation to address cardiovascular risk and heart failure.

• Chronic heart failure with reduced ejection fraction
• Atherosclerotic cardiovascular disease (ASCVD)
• Elevated lipoprotein(a) levels
• Hypertension
• Atrial fibrillation with stroke risk

Clinical trials test new pharmacologic agents, device‑based therapies, and lifestyle interventions to lower morbidity and mortality.

The site investigates immune‑mediated conditions, employing biomarkers to guide therapy selection for inflammatory and autoimmune disorders.

• Crohn’s disease
• Ulcerative colitis
• Atopic dermatitis (moderate to severe)
• Systemic lupus erythematosus
• Rare skin disorders such as Netherton syndrome

Trials evaluate biologics, JAK inhibitors, and novel small molecules, aiming to achieve durable remission and improve quality of life.

Focused investigations target chronic lung conditions, utilizing functional imaging and patient‑reported outcomes to assess respiratory health.

• Severe eosinophilic asthma
• Idiopathic pulmonary fibrosis
• Chronic obstructive pulmonary disease exacerbations
• Allergic rhinitis associated with asthma

Studies compare inhaled therapies, antifibrotic agents, and combination regimens to reduce exacerbations and preserve lung function.

Specialized imaging techniques support research on vision‑threatening ocular disorders.

• Neovascular age‑related macular degeneration
• Macular edema secondary to central retinal vein occlusion
• Diabetic retinopathy requiring anti‑VEGF therapy

Clinical programs assess the efficacy of intravitreal agents, laser interventions, and extended dosing schedules to improve visual outcomes.